Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actavis rhFSH versus GONAL-f in women undergoing assisted reproductive technology
2013-003788-67Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of follitropin alfa and follicle-stimulating hormone in female infertility (2 arms), sponsored by Allergan. Primary endpoint: Number of oocytes retrieved. Started Dec 2013; status: completed.
02
Drugs
follitropin alfafollicle-stimulating hormone
03
Conditions
female infertility
Beyond the preview
Go deeper on 2013-003788-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003788-67.